Abstract
Background
Laparoscopic hepatectomy (LH) is mostly performed to treat solitary tumors in the anterolateral liver segments (II, III, IVb, V, and VI). Few reports are available on LH for the treatment of hepatocellular carcinoma (HCC) in the posterosuperior liver segments (I, IVa, VII, and VIII), especially in association with cirrhosis. The purpose of this study was to investigate the safety and feasibility of LH in this clinical setting.
Methods
From January 2008 to January 2011, LH was conducted in 56 patients with HCC in the posterosuperior liver segments (PS group) and 70 patients with HCC in the anterolateral liver segments (AL group) who were admitted to Southwest Hospital of the Third Military Medical University, Chongqing, China. The clinical data and follow-up results in the two groups of patients were retrospectively analyzed.
Results
No patient in either group died during the perioperative period. Statistically significant differences were found between the PS and AL groups in terms of the operation time (217.5 ± 63.7 vs 176.8 ± 48.4 min, P = 0.000), volume of blood loss (295.5 ± 186.8 vs 220.4 ± 164.2 ml, P = 0.001), conversion rate from laparoscopy to laparotomy (17.9 vs 7.1 %, P = 0.031), transfusion rate (16.1 vs 4.3 %, P = 0.025), cases of hepatic inflow occlusion (38/18 vs 28/42, P = 0.002), and duration of inflow occlusion (41.3 ± 16.3 vs 31.3 ± 12.2 min, P = 0.005). Parameters with no significant differences between the two groups of patients included tumor size (4.0 ± 1.5 vs 3.9 ± 1.7 cm, P = 0.894), resection margin (1.7 ± 0.7 vs 1.8 ± 0.6 cm, P = 0.102), postoperative complication rate (16.1 vs 17.1 %, P = 0.873), postoperative anal exhaust time (3.2 ± 0.6 vs 3.0 ± 0.6 days, P = 0.361), and postoperative hospital stay (10.5 ± 2.7 vs 10.0 ± 0.6 days, P = 0.102). The serum alanine transaminase (ALT) and aspartate aminotransferase (AST) levels on postoperative days 1 and 3 were significantly higher in the PS group than in the AL group. There were no significant differences in the postoperative levels of the serum total bilirubin, albumin, ALT, or AST levels on postoperative days 5 and 7. After 2–48 months of follow-up, no significant differences in the 1- and 3-year overall survival rates (92.9 vs 95.7 %, P = 0.487 and 76.0 vs 76.8 %, P = 0.878, respectively) or 1- and 3-year disease-free survival rates (85.7 vs 87.1 %, P = 0.797 and 57.6 vs 56.4 %, P = 0.806, respectively) were noted between the two groups.
Conclusions
LH is safe and feasible for selected patients with HCC in the posterosuperior segments of the liver.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Koffron AJ, Auffenberg G, Kung R et al (2007) Evaluation of 300 minimally invasive liver resections at a single institution: less is more. Ann Surg 246:385–394
Edwin B, Nordin A, Kazaryan AM (2011) Laparoscopic liver surgery: new frontiers. Scand J Surg 100:54–65
Nguyen KT, Gamblin TC, Geller DA (2009) World review of laparoscopic liver resection-2,804 patients. Review 10:831–840
Joseph FB, Cherqui D, Geller DA et al (2009) The International Position on laparoscopic liver surgery: the Louisville statement, 2008. Ann Surg 250:825–830
Cho JY, Han HS, Yoon YS et al (2008) Experiences of laparoscopic liver resection including lesions in the posterosuperior segments of the liver. Surg Endosc 22:2344–2349
Airazat M, Kazaryan BI, Marangos RP et al (2011) Comparative evaluation of laparoscopic liver resection for posterosuperior and anterolateral segments. Surg Endosc 25:3881–3889
Chen H, Jeng KS, Huang SH et al (2013) Laparoscopic caudate hepatectomy for cancer—an innovative approach to the no-man’s land. J Gastrointest Surg 17:522–526
Yoon YS, Han HS, Cho JY et al (2010) Total laparoscopic liver resection for hepatocellular carcinoma located in all segments of the liver. Surg Endosc 24:1630–1637
Ishizawa T, Andrew A, Kokudo N et al (2012) Laparoscopic segmentectomy of the liver from segment I to VIII. Ann Surg 256:959–964
Fuchs BC, Hoshida Y, Fujii T et al (2014) Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma. Hepatology 59:1577–1590
Gagner M (2010) Small incision, big surgeon: laparoscopic liver resection for tumors without a doubt: comment on “laparoscopic liver resection for malignant and benign lesions: ten-year norwegian single-center experience”. Arch Surg 145:40–41
Imamura H, Sano K, Sugawara Y et al (2005) Assessment of hepatic reserve for indication of hepatic resection:decision tree incorporating indocyanine green test. J Hepatobiliary Pancreat Surg 12:16–22
Clavien PA, Petrowsky H, DeOliveira ML et al (2007) Strategies for safer liver surgery and partial liver transplantation. N Engl J Med 356(15):1545–1559
Si Y, Lau WY, Li GG et al (2011) A prospective randomized controlled trial to compare Pringle maneuver, hemihepatic vascular inflow occlusion, and main portal vein inflow occlusion in partial hepatectomy. Am J Surg 201:62–69
Dulucq JL, Wintringer P, Stabilini C et al (2006) Isolated laparoscopic resection of the hepatic caudate lobe: surgical technique and a report of 2 cases. Surg Laparosc Endosc Percutan Tech 16:32–35
Acknowledgments
This work was supported by the Foundation of Clinical Innovation Scientific Research, Southwest Hospital, Third Military Medical University (No. SWH2012LC10).
Conflict of interest
The authors declare that they have no potential or real conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
Lunjian Xiang and Le Xiao have contributed equally to this work.
Rights and permissions
About this article
Cite this article
Xiang, L., Xiao, L., Li, J. et al. Safety and Feasibility of Laparoscopic Hepatectomy for Hepatocellular Carcinoma in the Posterosuperior Liver Segments. World J Surg 39, 1202–1209 (2015). https://doi.org/10.1007/s00268-015-2946-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-015-2946-3